Ertugliflozin: Phase III data

The double-blind, placebo-controlled Phase III VERTIS Factorial trial in 1,233 Type II diabetics inadequately controlled on metformin alone showed that once-daily 5 and 15 mg ertugliflozin plus 100 mg Januvia sitagliptin each met the

Read the full 341 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE